177 related articles for article (PubMed ID: 11907945)
21. Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.
Reginster JY; Agnusdei D; Gennari C; Kicovic PM
Gynecol Endocrinol; 1999 Oct; 13(5):361-8. PubMed ID: 10599554
[TBL] [Abstract][Full Text] [Related]
22. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Gallagher JC; Kable WT; Goldgar D
Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
[TBL] [Abstract][Full Text] [Related]
23. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
24. Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.
Shadoan MK; Anthony MS; Rankin SE; Clarkson TB; Wagner JD
Metabolism; 2003 Sep; 52(9):1085-91. PubMed ID: 14506611
[TBL] [Abstract][Full Text] [Related]
25. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
[TBL] [Abstract][Full Text] [Related]
26. Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial.
Beardsworth SA; Kearney CE; Purdie DW
Br J Obstet Gynaecol; 1999 Jul; 106(7):678-83. PubMed ID: 10428524
[TBL] [Abstract][Full Text] [Related]
27. Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate.
Prior JC; Vigna YM; Wark JD; Eyre DR; Lentle BC; Li DK; Ebeling PR; Atley L
J Bone Miner Res; 1997 Nov; 12(11):1851-63. PubMed ID: 9383690
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
Ziaei S; Moaya M; Faghihzadeh S
Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
[TBL] [Abstract][Full Text] [Related]
29. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys.
Clarkson TB; Anthony MS; Mikkola TS; St Clair RW
Stroke; 2002 Nov; 33(11):2700-3. PubMed ID: 12411664
[TBL] [Abstract][Full Text] [Related]
30. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
[TBL] [Abstract][Full Text] [Related]
31. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
Valdivia I; Campodónico I; Tapia A; Capetillo M; Espinoza A; Lavín P
Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
[TBL] [Abstract][Full Text] [Related]
32. Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures.
Pavlov PW; Ginsburg J; Kicovic PM; van der Schaaf DB; Prelevic G; Bennink HJ
Gynecol Endocrinol; 1999 Aug; 13(4):230-7. PubMed ID: 10533157
[TBL] [Abstract][Full Text] [Related]
33. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
Diaby V; Perreault S; Lachaine J
Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
35. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
36. Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.
Rymer J; Robinson J; Fogelman I
Climacteric; 2002 Dec; 5(4):390-8. PubMed ID: 12626219
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss.
Mizunuma H; Shiraki M; Shintani M; Gorai I; Makita K; Itoga S; Mochizuki Y; Mogi H; Iwaoki Y; Kosha S; Yasui T; Ishihara O; Kurabayashi T; Kasuga Y; Hayashi K
J Bone Miner Metab; 2006; 24(1):11-5. PubMed ID: 16369892
[TBL] [Abstract][Full Text] [Related]
38. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
[TBL] [Abstract][Full Text] [Related]
40. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
